Bain Capital's leveraged buyouts sometimes led to layoffs, either soon after acquisition or later after the firm had concluded its role. Exactly how many jobs Bain Capital added compared to those lost because of these investments and buyouts is unknown, owing to a lack of records and Bain Capital's penchant for privacy on behalf of itself and its investors. Maximizing the value of acquired companies and the return to Bain's investors, not job creation, was the firm's primary investment goal. Bain Capital's acquisition of Ampad exemplified a deal where it profited handsomely from early payments and management fees, even though the subject company itself later went into bankruptcy. Dade Behring was another case where Bain Capital received an eightfold return on its investment, but the company itself was saddled with debt and laid off over a thousand employees before Bain Capital exited (the company subsequently went into bankruptcy, with more layoffs, before recovering and prospering). Referring to the layoffs that sometimes occurred, Romney said in 2007: "Sometimes the medicine is a little bitter but it is necessary to save the life of the patient. My job was to try and make the enterprise successful, and in my view the best security a family can have is that the business they work for is strong."